Miniature editors play a crucial role in genomic editing and gene therapy, particularly in addressing human genetic diseases caused by base mutations. Currently, approximately 60% of known human genetic diseases are attributed to base mutations. Traditional CRISPR technology poses risks such as double-stranded DNA breaks, whereas base editors can efficiently convert single bases at target sites without such breaks.